Cargando…
Efficacy and tolerability of combination therapy with alpha-blockers and phosphodiesterase-5 inhibitors compared with monotherapy for lower urinary tract symptoms: Protocol for a systematic review and network meta-analysis
PURPOSE: This study aimed to compare the efficacy and safety of combination therapy consisting of α-blockers and different phosphodiesterase type 5 inhibitors for lower urinary tract symptoms (LUTS) by performing a network meta-analysis. METHOD: Relevant articles were retrieved from the Cochrane Lib...
Autores principales: | Qiangzhao, Liu, Xiaofeng, Zhang, Fenghai, Zhou, Qiong, Lian, Fa, Zhang, Bohong, Guo, Xinsheng, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581165/ https://www.ncbi.nlm.nih.gov/pubmed/33120811 http://dx.doi.org/10.1097/MD.0000000000022834 |
Ejemplares similares
-
Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism: A rare case report and literature review
por: Wang, Dawei, et al.
Publicado: (2018) -
Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers: A Nationwide Population-Based Study
por: Wang, Yi-Chun, et al.
Publicado: (2016) -
Fenofibrate monotherapy-induced rhabdomyolysis in a patient with post-pancreatitis diabetes mellitus: A rare case report and a review of the literature
por: Zhou, Jingjing, et al.
Publicado: (2020) -
Intravenous compounding robots in pharmacy intravenous admixture services: A systematic review
por: Yang, Chunsong, et al.
Publicado: (2023) -
Platelet inhibitory activity, tolerability, and safety of vicagrel, a novel thienopyridine P2Y12 inhibitor
por: Li, Hui, et al.
Publicado: (2020)